5/6/2025

SAN DIEGO, May 06, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

Source: Yahoo

5/2/2025

Tandem Diabetes' Q1 bottom line lags estimate. However, the company experiences strong sales growth both in and outside the United States.

Source: Yahoo

5/2/2025

Tandem Diabetes Care ( NASDAQ:TNDM ) First Quarter 2025 Results Key Financial Results Revenue: US$234.4m (up 22% from...

Source: Yahoo

5/1/2025

Q1 2025 Tandem Diabetes Care Inc Earnings Call

Source: Yahoo

5/1/2025

Tandem Diabetes Care Inc (TNDM) reports robust growth and strategic advancements, while navigating competitive pressures and operational challenges.

Source: Yahoo

4/30/2025

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Source: Yahoo

4/30/2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.

Source: Yahoo

4/30/2025

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -11.67% and 6.44%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Source: Yahoo

4/30/2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full year’s revenue to be around $1 billion, close to analysts’ estimates. Its GAAP loss of $1.97 per share was significantly below analysts’ consensus estimates.

Source: Yahoo

4/30/2025

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2025 Earnings Conference Call April 30, 2025 4:30 PM ETCompany ParticipantsSusan Morrison - EVP & Chief...

Source: SeekingAlpha

4/30/2025

SAN DIEGO, April 30, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2025.

Source: Yahoo

4/29/2025

Here is a sneak peek into how these three MedTech stocks, ALGN, TNDM and ICLR, may fare in their quarterly results, slated to be released tomorrow.

Source: Yahoo

4/29/2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting results tomorrow after the bell. Here’s what you need to know.

Source: Yahoo

4/22/2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.

Source: Yahoo

4/17/2025

A robust diabetes market and international expansion raise investors' optimism for Tandem Diabetes.

Source: Yahoo

4/15/2025

Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Source: Yahoo

4/12/2025

With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares of top companies on the dip. Let's consider two examples: Teladoc Health (NYSE: TDOC) and Tandem Diabetes Care (NASDAQ: TNDM). Teladoc Health, a telemedicine specialist, might not feel a substantial direct impact from Trump's tariffs.

Source: Yahoo

4/11/2025

In the midst of significant market volatility, with major indices like the Dow and Nasdaq experiencing sharp declines following a brief rally, investors are increasingly focused on small-cap stocks as potential opportunities. The S&P 600 index for small-cap stocks has been particularly influenced by recent economic uncertainties and tariff developments, highlighting the importance of identifying companies that demonstrate resilience and potential for growth. In such an environment, a good...

Source: Yahoo

4/10/2025

Tandem Diabetes Care (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Source: Yahoo

4/3/2025

SAN DIEGO, April 03, 2025--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2025 results after the financial markets close on Wednesday, April 30, 2025. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2025 financial and operating results.

Source: Yahoo